Cristian Luput, Director at MAIA Biotechnology, Inc. (MAIA), bought 3,000 shares at $2.63 ($8K) on 2023-05-15, disclosed to the SEC on 2023-05-17.
Scheduled purchase ($8k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| MAIA | BUY | 2024-11-04 | $111K | — | Filing → |
| MAIA | BUY | 2024-03-15 | $162K | — | Filing → |
| MAIA | BUY | 2023-04-18 | $6K | — | Filing → |